1093.HK : Summary for CSPC PHARMA - Yahoo Finance

U.S. Markets closed

CSPC PHARMA (1093.HK)


HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
10.18+0.14 (+1.39%)
At close: 4:09PM HKT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close10.04
Open9.95
Bid10.14 x
Ask10.18 x
Day's Range9.95 - 10.18
52 Week Range6.30 - 10.44
Volume7,296,914
Avg. Volume14,602,764
Market Cap61.61B
Beta0.09
PE Ratio (TTM)36.12
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.01 (1.14%)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire6 days ago

    CSPC Pharmaceutical Announces 2016 Annual Results

    HONG KONG, March 20, 2017 /PRNewswire/ -- CSPC Pharmaceutical Group Limited (1093.HK) ("CSPC Pharmaceutical" or the "Group"), a leading pharmaceutical company in China, is pleased to announce its annual results for the year ended 31 December 2016 (the "Year"). During the Year, the Group recorded sales of approximately HK$12,369 million, representing an increase of 8.6% (or increase of 15.3% on a constant currency basis) over the previous year.

  • Why CSPC Pharmaceutical (CHPTY) Could Be an Impressive Growth Stock
    Zacks6 months ago

    Why CSPC Pharmaceutical (CHPTY) Could Be an Impressive Growth Stock

    CSPC Pharmaceutical (CHPTY) can be an exciting pick in the market as the firm saw robust EPS growth last year, and is looking great for this year too.

  • Is CSPC Pharmaceutical Group (CHPTY) a Great Growth Stock?
    Zacks6 months ago

    Is CSPC Pharmaceutical Group (CHPTY) a Great Growth Stock?

    One company that might be well-positioned for future earnings growth is CSPC Pharmaceutical Group Limited (CHPTY)